Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs
Jordana K Schmier,1 Carolyn K Hulme-Lowe,1 David W Covert21Exponent, Alexandria, VA, USA; 2Alcon Research Ltd., Fort Worth, TX, USAPurpose: To analyze patterns of use of adjunctive therapies among new initiators of topical prostaglandin analogs (PGAs) in a managed care population.Methods: The study...
Guardado en:
Autores principales: | Schmier JK, Hulme-Lowe CK, Covert DW |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ba97c6d01584518b3d18373ec1664b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs
por: Jordana K Schmier, et al.
Publicado: (2010) -
Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients
por: Michael B Horsley, et al.
Publicado: (2009) -
First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results
por: Jordana K Schmier, et al.
Publicado: (2010) -
First-year treatment costs among new initiators of topical prostaglandin analogs
por: Jordana K Schmier, et al.
Publicado: (2009) -
An updated estimate of costs of endophthalmitis following cataract surgery among Medicare patients: 2010–2014
por: Schmier JK, et al.
Publicado: (2016)